Test tubes in a metal rack against a light blue background

Resources & Knowledge Hub

  • Lipotris key visual: a prefilled syringe on a blue background with the claim Transform joint movement from sliding to rolling

    Synergy for the best outcomes. Technology behind Lipotris™

    When an innovative vision meets precisely engineered technology supported by controlled manufacturing technologies, it becomes possible to create a product that is ahead of its time. Most importantly, it remains compatible with the body’s natural functions, helping them and thereby becoming a valuable aid in the regeneration process. Learn more about Lipotris™ liposomal composite gel and what makes it worthy of this introduction.

  • An open hand of a specialist with a glowing molecular projection above it

    Unveiling the power of Wnt pathway: Implai’s breakthrough in medical devices

    In the realm of medical science, the Wnt signaling pathway stands as a beacon of promise, with its profound implications for cellular processes. Leading this frontier of innovation is Implai, whose meticulously tested medical devices harness the transformative potential of the Wnt pathway like never before.

  • A Monoshot vial among blue bubbles

    Unlocking the potential: the synergistic action of hyaluronic acid and platelet-rich plasma in joint regeneration

    At Implai, we recognize the critical importance of different forms of orthobiologic in promoting joint health, alleviating discomfort and finally improving patients quality of life. Through rigorous research and development, our expert team is determined to unlock their full therapeutic capabilities. Thus, by harnessing the full power of the synergistic effect of the most prominent orthobiologic products – hyaluronic acid and platelet-rich plasma – we aim to redefine standards in the treatment and management of joint-related conditions, offering hope to patients worldwide.

  • Two specialists working with laboratory equipment

    Results of an Independent Testing of the Xerthra™ System

    A more than sevenfold increase in platelet concentration and a recovery efficiency exceeding 87%. These are not merely marketing claims but the results of an independent evaluation of our Xerthra™ system, validating its performance and serving as a catalyst for meaningful scientific discussion within the medical community.